Month: November 2019

(Bloomberg) — Biogen Inc. shed more than $3 billion in market value in the past two trading sessions as a patent review of its top drug Tecfidera Wednesday raised concerns over a potential generic threat from Mylan NV.Shares fell as much as 3.7% on Thursday, the most in two months, extending losses for a third day. Analysts held different views on the trial, with Evercore ISI Umer Raffat saying the hearing went better-than-expected for Biogen, while RBC analyst Brian Abrahams said Mylan seemed to make “a slightly stronger case.”“In totality, the arguments and judges’ reactions seemed to favor MYL incrementally,” …read more […]

A bear signal flashing for Macy’s stock points to more downside ahead of Black Friday …read more […]

The resignation of top student loan official A. Wayne Johnson has caused a stir on Capitol Hill. …read more […]

Today we’ll take a closer look at Fastenal Company (NASDAQ:FAST) from a dividend investor’s perspective. Owning a… …read more […]

The world’s largest retailer’s third quarter results on Thursday showed that yet again, CEO Doug McMillon continues to pull almost all the right strings operationally. …read more […]

Disappointing earnings from Canopy Growth, Tilray and Cronos have investors hesitant to invest in the cannabis industry. Yahoo Finance’s Heidi Chung, Brian Cheung and Sibile Marcellus discuss with Entourage Effect Capital CEO Matt Hawkins on YFi AM …read more […]

Does the November share price for Smith Micro Software, Inc. (NASDAQ:SMSI) reflect what it’s really worth? Today, we… …read more […]

(Bloomberg) — Canopy Growth Corp. shares fell to the lowest in nearly two years after the pot company reported revenue that missed the lowest analyst estimate and a loss that one analyst called “astounding.”The world’s largest cannabis company by market value also said it’s unlikely to meet its previous guidance of C$250 million in revenue by the fiscal fourth quarter, which ends March 31.Shares fell as much as 16% Thursday to C$20.55, the lowest since December 2017. The stock has lost more than 40% since the beginning of the year.Canopy took a restructuring charge of C$32.7 million ($24.6 million) for …read more […]